484,00 € excl.VAT
This antibody reacts with the CD19- antigen (B4-antigen), which is expressed on human B lymphocytes. The monoclonal antibody is B lineage-specific and reacts with early B-cell precursors, pre-B-cells, B-cells, intermediate B-cells, mature B-cells and some plasmacytoid cells, also reacts with pre-B-cell- lines, B lymphoblastoid cell-lines and Burkitt cell- lines, and with 50% of myeloma cell-lines. Plasma cells were found to be negative.
| Conjugated | |
|---|---|
| Size | |
| Regulatory Status | |
| Clone | |
| Format | |
| Species Reactivity | |
| Isotype | |
| Tested Applications | |
| Clonality | |
| UniProt | |
| Mw | |
| Protocol | |
| Storage | Store in the dark at 2-8°C. |
| Buffer | The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3). |
| Immunogen | Human CD19 purified from tonsil. |
| Concentration | 0,2 mg/ml |
CD19, clone A3-B1, is a mAb intended for identification/enumeration of human B cells by FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.
Technical Data Sheet (TDS) – (English). Safety Sheet (MSDS) – (English)
| Product description | Reference | Title | Authors | Journal | Year | |
|---|---|---|---|---|---|---|
| Product description | Reference | Title | Authors | Journal | Year |